Live News EQUITY FLASH L impact Nov 05, 2026, 11:50 AM UTC Lilly’s retatrutide reduced knee osteoarthritis pain in a Phase 3 trial The Phase 3 trial reported reduced knee osteoarthritis pain with retatrutide. LLY SquawkNews Desk